Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Identify scenarios where active funds may outperform, focusing on market environments, fees, and your risk tolerance.
14,457 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Investors are pouring capital into a new class of AI startups focused on world models, a movement led by tech founder...
Bitcoin’s rally back above $60,000 reversed sharply after June 25 inflation data, triggering a wave of long liquidati...
Bright MLS will begin feeding its broker listings into Google search results via HouseCanary ComeHome, expanding how ...
Stellar leads in on-chain real-world asset tokenization, but XRP still dominates in price. The divergence spotlights ...
Autheo launches its decentralized OS Mainnet, a coordination layer that unifies Web, blockchain, and AI across networ...
Business and academia are joining forces to accelerate practical AI, with new joint labs, funding, and internships sh...
A new AI model named GROK forecasts XRP reaching $4-$6 by December 2026, contingent on regulatory certainty and expan...
The june jobs report came in well below forecasts, adding 57,000 payrolls and prompting a shift in Fed expectations a...
On Independence Day, traditional markets pause while Bitcoin continues to trade worldwide. The day showcases how bitc...
Rafael Nadal is redefining his legacy, launching a hotel portfolio after amassing a $220 million fortune. He says ret...
Five years after a split investment in Bitcoin and XRP, the outcomes diverged dramatically amid regulation and instit...